Post hoc analysis of LEADER data revealed a persistent increase in the overall risk of biliary tract-related events and gallbladder diseases, consistently observed across four categories: uncomplicated gallbladder stones, complicated gallbladder stones, cholecystitis with/without gallbladder stones, and biliary obstruction [34]
There is no confirmed UK launch date
For the side effect phenotypes, the effect size represents log-odds ratio, whereas for the efficacy phenotype, the effect size represents percentage BMI change
Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals: a systematic review and meta-analysis
GIP helps retatrutide work as a treatment for obesity
Conducted among both healthy individuals and patients with type 2 diabetes, the MGH trial showed that GLP-1 (7-37) had potent insulinotropic effects in both groups